What is the recommended duration of amoxicillin‑clavulanate 1 g (1000 mg) therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin-Clavulanate 1g Duration

For most adult infections, amoxicillin-clavulanate 1g should be administered for 5-7 days, with specific exceptions requiring longer courses based on infection type and patient age.

Duration by Indication

Acute Bacterial Rhinosinusitis (ABRS)

  • Adults: 5-7 days is the recommended duration for uncomplicated ABRS 1
  • Children: 10-14 days remains the standard despite shorter adult courses 1
  • The 2012 IDSA guideline specifically supports this shorter adult duration based on moderate-quality evidence

Community-Acquired Pneumonia (CAP)

  • 5-7 days for low to moderate severity CAP in adults, provided the patient is afebrile for 48 hours and clinically stable 2
  • Clinical stability criteria include: temperature ≤37.8°C, heart rate ≤100 bpm, respiratory rate ≤24 breaths/min, systolic BP ≥90 mmHg, oxygen saturation ≥90%, ability to maintain oral intake, and normal mental status
  • Continue until the patient is well for 7 days (generally 10-14 days total) for respiratory tract infections 3

Chronic Rhinosinusitis

  • 14 days (3 weeks in some studies) for chronic rhinosinusitis based on comparative trials 4
  • Studies used amoxicillin-clavulanate 625mg three times daily for 3 weeks with comparable efficacy to other regimens

Lower Respiratory Tract Infections (COPD Exacerbations)

  • At least 7 days for community-acquired lower respiratory tract infections managed in hospital settings 3
  • Assess clinical response at day 5-7 for improvement of symptoms

Key Dosing Considerations

Standard Adult Dosing (FDA-Approved) 5

  • Mild-moderate infections: 500mg/125mg every 12 hours OR 250mg/125mg every 8 hours
  • Severe infections/respiratory tract: 875mg/125mg every 12 hours OR 500mg/125mg every 8 hours
  • The 1g dose referenced in your question likely refers to the 875mg/125mg formulation (total ~1000mg)

High-Dose Regimens

When treating infections with suspected resistant pathogens (recent antibiotic use within 4-6 weeks, high local resistance rates):

  • Adults: 2g/125mg (amoxicillin component) twice daily 1
  • Children: 90mg/kg/day divided twice daily 1

Important Clinical Caveats

Shorter courses (5-7 days) are appropriate when:

  • Patient demonstrates clinical improvement within 72 hours
  • No risk factors for resistant organisms
  • Adequate source control achieved
  • Patient reaches clinical stability criteria

Longer courses (10-14 days) are necessary for:

  • Pediatric patients with ABRS or acute otitis media 1, 6
  • Patients not improving after initial 3-5 days of therapy 7
  • Severe infections or immunocompromised hosts
  • Suspected Legionella pneumophila (requires 21 days) 3

Common pitfall: The evidence strongly supports that 10-day courses may be unnecessarily long for many adult infections, yet many clinicians default to this duration. The 2012 IDSA guideline explicitly recommends 5-7 days for adult ABRS, representing a significant departure from older 10-14 day recommendations 1. However, this shorter duration does NOT apply to children, where 10-14 days remains standard due to different pharmacokinetics and immune responses.

Renal adjustment required: Patients with GFR <30 mL/min should not receive the 875mg/125mg dose and require dosing modifications 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.